Researchers at the British Museum and Durham University in the U.K. have located a skeleton more than 3,000 years old that they say represents the oldest complete example of a human being with metastatic cancer.

Could a home colon cancer test boost screening rates, especially in underserved populations? That was the question asked by researchers at the Kaiser Permanente Center for Health Research.

According to the World Cancer report released by the World Health Organization (WHO) on World Cancer Day, cancer cases will increase to 57 percent within 20 years, as reported by CNN on Feb. 4.

Pairing the diabetes drug, metformin, with chemoradiation therapy treatment for aggressive lung cancer may slow tumor growth and recurrence, according to researchers at the Perelman School of Medicine at the University of Pennsylvania.

Following the National Lung Screening Trial, which demonstrated a 20 percent reduction in lung cancer mortality for low-dose CT screening in high-risk patients, some have clamored for expanded CT screening efforts.

It is not uncommon for patients who’ve been diagnosed with cancer to feel stigmatized for behaviors that could have led to their disease, such as smoking or tanning.

Buckyballs, the soccer ball-shaped carbon nanoparticles, have shown promise for applications in medicine, but how they are created is a mystery.

Research published recently in the New England Journal of Medicine (NEJM) looked at a predictive tool that estimates the probability that lung nodules detected through low-dose CT screening are malignant. For colorful take on the findings, check out the accompanying NEJM Quick Take animation.

Last month, a study published in The New England Journal of Medicine (NEJM) demonstrated how radium-223 could reduce the risk of death in patients with castration-resistant prostate cancer by targeting bone metastases, a common complication.

The American Cancer Society celebrated the 100th anniversary of its founding in May.

Researchers at Purdue University in West Lafayette, Ind., are working an imaging technology that combines atomic force microscopy and nuclear MR to simultaneously study the mechanical and biochemical behavior of cells.

Exact Sciences has developed a stool-based screening test that detected 92 percent of cancers found on colonoscopy and 42 percent of precancerous polyps. The results fell shy of the company’s goal of a 50 percent polyp detection rate, according to an article in the New York Times; however, Exact Sciences indicated its plans to file for FDA approval of its Cologuard test.